KOVALCHUK, SOFYA
 Distribuzione geografica
Continente #
NA - Nord America 2.738
EU - Europa 1.665
AS - Asia 1.062
SA - Sud America 137
Continente sconosciuto - Info sul continente non disponibili 36
AF - Africa 33
OC - Oceania 6
Totale 5.677
Nazione #
US - Stati Uniti d'America 2.682
RU - Federazione Russa 571
IT - Italia 441
SG - Singapore 276
CN - Cina 230
HK - Hong Kong 189
PL - Polonia 174
IE - Irlanda 126
VN - Vietnam 108
BR - Brasile 104
DE - Germania 83
SE - Svezia 73
KR - Corea 66
IN - India 44
CH - Svizzera 43
FI - Finlandia 37
CA - Canada 36
FR - Francia 36
GB - Regno Unito 36
BD - Bangladesh 26
JP - Giappone 25
JO - Giordania 22
ID - Indonesia 15
NL - Olanda 10
ZA - Sudafrica 10
AR - Argentina 9
IQ - Iraq 9
TR - Turchia 9
EC - Ecuador 8
PK - Pakistan 8
MA - Marocco 7
MX - Messico 7
AT - Austria 6
AU - Australia 6
CI - Costa d'Avorio 6
PH - Filippine 6
UA - Ucraina 6
UZ - Uzbekistan 6
VE - Venezuela 6
CO - Colombia 4
GT - Guatemala 4
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
MY - Malesia 3
TJ - Tagikistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
BY - Bielorussia 2
CL - Cile 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
AL - Albania 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LT - Lituania 1
MM - Myanmar 1
MQ - Martinica 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.641
Città #
Santa Clara 626
Ashburn 357
Fairfield 181
Singapore 178
Warsaw 170
Hong Kong 158
Dublin 125
Woodbridge 107
Chandler 103
San Jose 102
Houston 93
Seattle 89
Cambridge 84
Milan 80
Beijing 67
Wilmington 61
Ann Arbor 60
Seoul 60
Moscow 43
Munich 42
Bern 40
Florence 37
Hanoi 34
Rome 34
Council Bluffs 33
Ho Chi Minh City 32
Los Angeles 31
Altamura 29
Boston 29
Lawrence 28
Princeton 28
Shanghai 28
The Dalles 28
New York 27
Buffalo 26
Mumbai 23
Chicago 22
Lauterbourg 21
Dallas 16
Helsinki 15
Tokyo 15
Hefei 13
Lappeenranta 13
Toronto 13
Naples 12
San Diego 11
Bologna 10
São Paulo 10
Dearborn 9
Medford 9
Phoenix 9
Turin 9
Clifton 8
Denver 8
Dong Ket 8
Falkenstein 8
Jakarta 8
Johannesburg 8
Kent 8
Paris 8
Boardman 7
London 7
Turku 7
Abidjan 6
Chennai 6
Frankfurt am Main 6
Guangzhou 6
Orem 6
Union City 6
Boydton 5
Hải Dương 5
Melbourne 5
Montreal 5
Norwalk 5
Nuremberg 5
Pisa 5
Redwood City 5
Secaucus 5
Sesto Fiorentino 5
Tianjin 5
Baghdad 4
Bremen 4
Canton 4
Curitiba 4
Istanbul 4
Pune 4
Stockholm 4
Thiene 4
Yubileyny 4
Amman 3
Bari 3
Biên Hòa 3
Brescia 3
Brooklyn 3
Gangdong-gu 3
Genoa 3
Guatemala City 3
Hounslow 3
Las Vegas 3
Lucca 3
Totale 3.725
Nome #
THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA 297
The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study 289
The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas 276
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 270
RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI 269
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 268
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 262
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 229
DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI 226
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 221
Safety Profile of Idelalisib in Patients with Refractory Follicular Lymphoma: Interim Analysis of a Noninterventional Study 219
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 210
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 209
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 206
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 205
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study 205
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 203
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 200
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL) 199
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 189
Multicenter Long Term Follow-up in Hairy Cell Leukemia Patients Treated with Cladribine: A Thirty-Year Experience 185
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen 183
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 179
Long-Term results of the FOLL05 trial comparing R-CVP Versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma 167
Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation 165
Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study 146
Totale 5.677
Categoria #
all - tutte 15.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022153 0 0 0 16 6 10 8 11 16 10 23 53
2022/2023556 40 77 38 28 30 94 67 28 66 4 15 69
2023/2024313 8 28 32 10 32 39 24 54 11 34 25 16
2024/20251.652 42 146 88 276 496 264 17 94 78 41 49 61
2025/20261.600 216 192 99 116 204 47 195 74 96 112 44 205
2026/2027305 93 36 106 70 0 0 0 0 0 0 0 0
Totale 5.677